Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Non-structural carbohydrates in woody plants compared among laboratories.

Quentin AG, Pinkard EA, Ryan MG, Tissue DT, Baggett LS, Adams HD, Maillard P, Marchand J, Landhäusser SM, Lacointe A, Gibon Y, Anderegg WR, Asao S, Atkin OK, Bonhomme M, Claye C, Chow PS, Clément-Vidal A, Davies NW, Dickman LT, Dumbur R, Ellsworth DS, Falk K, Galiano L, Grünzweig JM, Hartmann H, Hoch G, Hood S, Jones JE, Koike T, Kuhlmann I, Lloret F, Maestro M, Mansfield SD, Martínez-Vilalta J, Maucourt M, McDowell NG, Moing A, Muller B, Nebauer SG, Niinemets Ü, Palacio S, Piper F, Raveh E, Richter A, Rolland G, Rosas T, Saint Joanis B, Sala A, Smith RA, Sterck F, Stinziano JR, Tobias M, Unda F, Watanabe M, Way DA, Weerasinghe LK, Wild B, Wiley E, Woodruff DR.

Tree Physiol. 2015 Nov;35(11):1146-65. doi: 10.1093/treephys/tpv073. Epub 2015 Sep 29.

PMID:
26423132
2.

Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring.

Termentzi A, Khouri I, Gaslonde T, Prado S, Saint-Joanis B, Bardou F, Amanatiadou EP, Vizirianakis IS, Kordulakova J, Jackson M, Brosch R, Janin YL, Daffé M, Tillequin F, Michel S.

Eur J Med Chem. 2010 Dec;45(12):5833-47. doi: 10.1016/j.ejmech.2010.09.048. Epub 2010 Oct 1.

PMID:
20961671
3.

[A promising new class of antituberculous molecules].

Saint-Joanis B, Brosch R.

Med Sci (Paris). 2009 Aug-Sep;25(8-9):663-5. doi: 10.1051/medsci/2009258-9663. French. No abstract available.

4.

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Makarov V, Manina G, Mikusova K, Möllmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST.

Science. 2009 May 8;324(5928):801-4. doi: 10.1126/science.1171583. Epub 2009 Mar 19.

5.

Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity.

Alvey L, Prado S, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL.

Eur J Med Chem. 2009 Jun;44(6):2497-505. doi: 10.1016/j.ejmech.2009.01.017. Epub 2009 Jan 29.

PMID:
19232450
6.

A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.

Alvey L, Prado S, Huteau V, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL.

Bioorg Med Chem. 2008 Sep 1;16(17):8264-72. doi: 10.1016/j.bmc.2008.06.057. Epub 2008 Aug 3.

PMID:
18752967
7.

A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.

Székely R, Wáczek F, Szabadkai I, Németh G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pató J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Kéri G.

Immunol Lett. 2008 Mar 15;116(2):225-31. doi: 10.1016/j.imlet.2007.12.005. Epub 2008 Jan 8.

PMID:
18258308
8.

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues.

Prado S, Janin YL, Saint-Joanis B, Brodin P, Michel S, Koch M, Cole ST, Tillequin F, Bost PE.

Bioorg Med Chem. 2007 Mar 1;15(5):2177-86. Epub 2006 Dec 12.

PMID:
17208445
9.

The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth.

Fernandez P, Saint-Joanis B, Barilone N, Jackson M, Gicquel B, Cole ST, Alzari PM.

J Bacteriol. 2006 Nov;188(22):7778-84. Epub 2006 Sep 15.

10.

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence.

Saint-Joanis B, Demangel C, Jackson M, Brodin P, Marsollier L, Boshoff H, Cole ST.

J Bacteriol. 2006 Sep;188(18):6669-79.

11.

Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress.

Guimarães BG, Souchon H, Honoré N, Saint-Joanis B, Brosch R, Shepard W, Cole ST, Alzari PM.

J Biol Chem. 2005 Jul 8;280(27):25735-42. Epub 2005 May 10.

12.
13.

Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?

Banu S, Honoré N, Saint-Joanis B, Philpott D, Prévost MC, Cole ST.

Mol Microbiol. 2002 Apr;44(1):9-19.

14.

The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.

Heym B, Saint-Joanis B, Cole ST.

Tuber Lung Dis. 1999;79(4):267-71. Review. No abstract available.

PMID:
10692996
15.

Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.

Saint-Joanis B, Souchon H, Wilming M, Johnsson K, Alzari PM, Cole ST.

Biochem J. 1999 Mar 15;338 ( Pt 3):753-60.

16.

Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.

Heym B, Stavropoulos E, Honoré N, Domenech P, Saint-Joanis B, Wilson TM, Collins DM, Colston MJ, Cole ST.

Infect Immun. 1997 Apr;65(4):1395-401.

17.

The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne.

Cornillot E, Saint-Joanis B, Daube G, Katayama S, Granum PE, Canard B, Cole ST.

Mol Microbiol. 1995 Feb;15(4):639-47.

PMID:
7783636
18.

Molecular genetic analysis of the nagH gene encoding a hyaluronidase of Clostridium perfringens.

Canard B, Garnier T, Saint-Joanis B, Cole ST.

Mol Gen Genet. 1994 Apr;243(2):215-24.

PMID:
8177218
19.

Genomic diversity and organization of virulence genes in the pathogenic anaerobe Clostridium perfringens.

Canard B, Saint-Joanis B, Cole ST.

Mol Microbiol. 1992 Jun;6(11):1421-9.

PMID:
1625573
20.
21.

Molecular characterisation of the colicin E2 operon and identification of its products.

Cole ST, Saint-Joanis B, Pugsley AP.

Mol Gen Genet. 1985;198(3):465-72.

PMID:
3892228

Supplemental Content

Loading ...
Support Center